Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

ARRY-614 active in phase I trial

July 5, 2012

Dinaciclib is highly active in phase I trial in chronic lymphocytic leukemia

July 4, 2012

Navitoclax administered with bendamustine/rituximab in phase I study

July 4, 2012

Scientists discover cause of Sengers syndrome / News in Context

July 4, 2012

AMG-900 shows promise in first-in-human trial

July 4, 2012

Safety results presented on new MedImmune immunotherapeutic

July 4, 2012

Milatuzumab evaluated in elderly patients with chronic lymphocytic leukemia

July 3, 2012

Early-stage clinical results disclosed on prodrug for cancer

July 3, 2012

Melatonin MT2 receptor agonist shows promise to treat sleep-related disorders

July 3, 2012

Scientists link new mutations to orofacial clefts and cancer risk

July 3, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...